174 related articles for article (PubMed ID: 3006333)
1. Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell lines.
Koizumi S; Fujiwara S; Kikuta H; Okano M; Imai S; Mizuno F; Osato T
Virology; 1986 Apr; 150(1):161-9. PubMed ID: 3006333
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.
Sairenji T; Bertoni G; Medveczky MM; Medveczky PG; Nguyen QV; Humphreys RE
J Virol; 1988 Aug; 62(8):2614-21. PubMed ID: 2839689
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
Finke J; Rowe M; Kallin B; Ernberg I; Rosén A; Dillner J; Klein G
J Virol; 1987 Dec; 61(12):3870-8. PubMed ID: 2824821
[TBL] [Abstract][Full Text] [Related]
4. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
Vestergaard BF; Hesse J; Norrild B; Klein G
Int J Cancer; 1978 Mar; 21(3):323-8. PubMed ID: 75856
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody specific for capsid antigen of Epstein-Barr virus.
Takada K; Fujiwara S; Yano S; Osato T
Med Microbiol Immunol; 1983; 171(4):225-31. PubMed ID: 6304479
[TBL] [Abstract][Full Text] [Related]
6. Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody.
Lin JC; Choi EI; Pagano JS
J Virol; 1985 Mar; 53(3):793-9. PubMed ID: 2983091
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.
Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G
Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
[TBL] [Abstract][Full Text] [Related]
9. A comparison of Epstein-Barr virus specific proteins expressed by three Epstein-Barr virus isolates using specific monoclonal antibodies.
Tsai CH; Glaser R
Intervirology; 1991; 32(6):376-82. PubMed ID: 1657827
[TBL] [Abstract][Full Text] [Related]
10. Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals.
Zhu XX; Zeng Y; Wolf H
Int J Cancer; 1986 May; 37(5):689-91. PubMed ID: 3009331
[TBL] [Abstract][Full Text] [Related]
11. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen.
Hank JA; Sondel PM
Hum Immunol; 1984 Apr; 9(4):211-9. PubMed ID: 6201468
[TBL] [Abstract][Full Text] [Related]
12. Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.
Fresen KO; Hausen H
Int J Cancer; 1976 Feb; 17(2):161-6. PubMed ID: 175026
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of Epstein-Barr virus membrane antigens defined with monoclonal antibodies.
Yokochi T; Clark EA; Kimura Y
Virology; 1986 Jan; 148(1):114-20. PubMed ID: 3002025
[TBL] [Abstract][Full Text] [Related]
14. Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein.
Qualtiere LF; Chase R; Vroman B; Pearson GR
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):616-20. PubMed ID: 6176998
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus strain- and group-specific antigenic determinants detected by monoclonal antibodies.
Mueller-Lantzsch N; Georg-Fries B; Herbst H; zur Hausen H; Braun DG
Int J Cancer; 1981 Sep; 28(3):321-7. PubMed ID: 6172392
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
17. Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen.
Kishishita M; Luka J; Vroman B; Poduslo JF; Pearson GR
Virology; 1984 Mar; 133(2):363-75. PubMed ID: 6324457
[TBL] [Abstract][Full Text] [Related]
18. Productive Epstein-Barr viral infection of the human lymphoblastoid cell line 6410 with release of early antigen inducing and transforming virus.
Traul KA; Stephens R; Gerber P; Peterson WD
Int J Cancer; 1977 Aug; 20(2):247-55. PubMed ID: 197026
[TBL] [Abstract][Full Text] [Related]
19. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
Sairenji T; Nguyen QV; Woda B; Humphreys RE
J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody that neutralizes Epstein-Barr virus DNA polymerase activity.
Tsai CH; Williams MV; Glaser R
Intervirology; 1990; 31(2-4):215-22. PubMed ID: 2165046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
